glp-1/gcgr dual agonist Glucagon Receptor - an overview Media Centre | EASD

I keep an eye on this space because, despite considerable issues with nausea, vomiting, muscle loss, and even rare cases of sudden blindness, the GLP-1 RA drugs may offer the first real hope for patients with metabolic syndrome associated with chronic ulcers

Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled using random-effects meta-analysis

I ate because I was afraid, and I ate because it was a FU to my self-esteem, Bates explained

Key Findings 12.2

& Wu, J

Proper dosing schedules become essential because higher doses lead to more frequent side effects such as gastrointestinal upset, and the side effects can be managed by using the minimum effective dose or slow titration (Figure 2)